Reuters said that the Hungarian government also passed a decree on the 14th, allowing it to purchase outside the EU centralized plan. Guyash Galgoi, Minister of the Prime Minister's Office of Hungary, said on the 14th that Hungary had signed a contract to purchase Sinopharm's new vaccine, and the first batch of vaccines delivered reached 1 million doses.
[Global Times reporter Li Zhen, Wang Chuanbao] According to Reuters, the Hungarian government said that it had reached a purchase agreement with Sinopharm. Hungarian Prime Minister Orban said on the national radio on the 15th that the Hungarian Drug Administration is expected to give a "clear answer" in a few days on whether the Chinese national drug vaccine can be used for mass vaccination in the country. According to the report, if approved, Hungary will be the first EU country to accept the Chinese vaccine.
Orban said on the 15th that Hungary is well prepared for vaccination, but our progress is slow because there is not enough vaccine. He said that the UK, which has left the EU, has so far vaccinated 4% of its population, while the EU's vaccination rate is less than 1% due to lack of vaccination. At this moment, the EU should not just pretend, but should strive to obtain vaccines. He said that as long as the Hungarian health department approves, Hungary can get a large number of Chinese vaccines, and there will be clear approval results in the near future, and Chinese vaccines are expected to enter Hungary soon. At present, Hungary has signed the contract for the first batch of 1 million doses of vaccines with Sinopharm, which can be delivered to Hungary as long as the Hungarian health department approves.
Reuters said that the Hungarian government also passed a decree on the 14th, allowing it to purchase outside the EU centralized plan. Guyash Galgoi, Minister of the Prime Minister's Office of Hungary, said on the 14th that Hungary had signed a contract to purchase Sinopharm's new vaccine, and the first batch of vaccines delivered reached 1 million doses. At the press conference on the same day, he said that the vaccine delivery speed under the EU plan was too slow, and the weekly delivery volume was less than 100000 doses. Hungary will continue to negotiate with Russia and China to buy more vaccines.
President Joko of Indonesia and President Erdogan of Turkey were inoculated with the new coronal vaccine developed by Sinovac on the 13th and 14th respectively. According to the website of Turkish Radio and Television General Station on the 15th, it is of great significance for Erdogan to be publicly vaccinated with Chinese vaccine. After vaccination, he said that members of the Central Decision making and Executive Committee of the Justice and Development Party, the ruling party of Turkey, had been vaccinated with him. He called on leaders of other political parties and parliamentarians to join the ranks of vaccinators, and encouraged the public to accept and approve the vaccination.
At present, five vaccines developed by Chinese enterprises have been carried out phase III clinical trials in many countries around the world. According to the Russian satellite network reported on the 15th, the news office of Petrovax told the media that the mid-term results of the local three phase clinical trials proved that the Ad5-nCoV new coronal vaccine jointly developed by China Concino Biological Company and the Academy of Military Medical Sciences was safe and effective. The data analysis of 200 of 500 volunteers showed that 92.5% of the volunteers had produced a high level of new coronavirus antibody, and no serious adverse reactions were found during the test. Bloomberg said on the 15th that Petrovax had submitted an application for the registration of Concino vaccine in Russia, which may mark the first time that the vaccine has been approved outside China. At the same time, Phase III clinical trials of the vaccine have been carried out in Pakistan and other countries.